FDA Warns Of Excessive Bleeding Linked To J&J’s COVID-19 Vaccine

By Beth Wang / January 12, 2022 at 2:21 PM
FDA warns there’s a serious risk of excessive bleeding and bruising that can occur after use of the Johnson & Johnson COVID-19 vaccine, and the agency has updated its fact sheets for health care providers and patients to include information about the condition, known as Immune Thrombocytopenia (ITP). The concerns of ITP come just one month after the Centers for Disease Control and Prevention’s vaccine advisers voted unanimously in favor of recommending use of the currently authorized mRNA vaccines for...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.